Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 235

1.

Characterization of additional genetic events in childhood acute lymphoblastic leukemia with TEL/AML1 gene fusion: a molecular cytogenetics study.

Ma SK, Wan TS, Cheuk AT, Fung LF, Chan GC, Chan SY, Ha SY, Chan LC.

Leukemia. 2001 Sep;15(9):1442-7.

PMID:
11516105
2.

AML1 gene over-expression in childhood acute lymphoblastic leukemia.

Mikhail FM, Serry KA, Hatem N, Mourad ZI, Farawela HM, El Kaffash DM, Coignet L, Nucifora G.

Leukemia. 2002 Apr;16(4):658-68.

3.

Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemia.

Martínez-Ramírez A, Urioste M, Contra T, Cantalejo A, Tavares A, Portero JA, López-Ibor B, Bernacer M, Soto C, Cigudosa JC, Benítez J.

Haematologica. 2001 Dec;86(12):1245-53.

4.

TEL-AML1 translocations with TEL and CDKN2 inactivation in acute lymphoblastic leukemia cell lines.

Kim DH, Moldwin RL, Vignon C, Bohlander SK, Suto Y, Giordano L, Gupta R, Fears S, Nucifora G, Rowley JD.

Blood. 1996 Aug 1;88(3):785-94.

5.

Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster Study Group.

Borkhardt A, Cazzaniga G, Viehmann S, Valsecchi MG, Ludwig WD, Burci L, Mangioni S, Schrappe M, Riehm H, Lampert F, Basso G, Masera G, Harbott J, Biondi A.

Blood. 1997 Jul 15;90(2):571-7.

6.

The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia.

Raynaud S, Cave H, Baens M, Bastard C, Cacheux V, Grosgeorge J, Guidal-Giroux C, Guo C, Vilmer E, Marynen P, Grandchamp B.

Blood. 1996 Apr 1;87(7):2891-9.

7.

Chromosomal changes detected by fluorescence in situ hybridization in patients with acute lymphoblastic leukemia.

Zhang L, Parkhurst JB, Kern WF, Scott KV, Niccum D, Mulvihill JJ, Li S.

Chin Med J (Engl). 2003 Sep;116(9):1298-303.

PMID:
14527352
8.

Low incidence of TEL/AML1 fusion and TEL deletion in Korean childhood acute leukemia by extra-signal fluorescence in situ hybridization.

Park KU, She CJ, Shin HY, Ahn HS, Kim CJ, Cho BK, Cho HI, Lee DS.

Cancer Genet Cytogenet. 2001 Apr 1;126(1):73-7.

PMID:
11343784
9.

Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia.

Nakao M, Yokota S, Horiike S, Taniwaki M, Kashima K, Sonoda Y, Koizumi S, Takaue Y, Matsushita T, Fujimoto T, Misawa S.

Leukemia. 1996 Sep;10(9):1463-70.

PMID:
8751464
10.

TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia.

Cayuela JM, Baruchel A, Orange C, Madani A, Auclerc MF, Daniel MT, Schaison G, Sigaux F.

Blood. 1996 Jul 1;88(1):302-8.

11.

Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.

Stams WA, den Boer ML, Beverloo HB, Meijerink JP, van Wering ER, Janka-Schaub GE, Pieters R.

Clin Cancer Res. 2005 Apr 15;11(8):2974-80.

12.

Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse.

Harbott J, Viehmann S, Borkhardt A, Henze G, Lampert F.

Blood. 1997 Dec 15;90(12):4933-7.

13.

Fluorescence in situ hybridization analysis of 12;21 translocation in Japanese childhood acute lymphoblastic leukemia.

Eguchi-Ishimae M, Eguchi M, Tanaka K, Hamamoto K, Ohki M, Ueda K, Kamada N.

Jpn J Cancer Res. 1998 Jul;89(7):783-8.

PMID:
9738986
14.

[Cytogenetic and FISH findings are complementary in childhood ALL].

Haltrich I, Csóka M, Kovács G, Fekete G.

Magy Onkol. 2008 Sep;52(3):283-91. doi: 10.1556/MOnkol.52.2008.3.6. Hungarian.

PMID:
18845499
15.

Analysis of ETV6/AML1 abnormalities in acute lymphoblastic leukaemia: incidence, alternative spliced forms and minimal residual disease value.

Codrington R, O'Connor HE, Jalali GR, Carrara P, Papaioannou M, Hart SM, Hoffbrand AV, Potter M, Prentice HG, Harrison CJ, Foroni L.

Br J Haematol. 2000 Dec;111(4):1071-9.

PMID:
11167742
16.

AML1 gene amplification: a novel finding in childhood acute lymphoblastic leukemia.

Niini T, Kanerva J, Vettenranta K, Saarinen-Pihkala UM, Knuutila S.

Haematologica. 2000 Apr;85(4):362-6.

17.

Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in human early B-lineage leukemia cell lines.

Uphoff CC, MacLeod RA, Denkmann SA, Golub TR, Borkhardt A, Janssen JW, Drexler HG.

Leukemia. 1997 Mar;11(3):441-7.

PMID:
9067587
18.

TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia.

Ramakers-van Woerden NL, Pieters R, Loonen AH, Hubeek I, van Drunen E, Beverloo HB, Slater RM, Harbott J, Seyfarth J, van Wering ER, Hählen K, Schmiegelow K, Janka-Schaub GE, Veerman AJ.

Blood. 2000 Aug 1;96(3):1094-9.

19.
20.

Interphase FISH on TEL/AML1 positive acute lymphoblastic leukemia relapses--analysis of clinical relevance of additional TEL and AML1 copy number changes.

Peter A, Heiden T, Taube T, Körner G, Seeger K.

Eur J Haematol. 2009 Nov;83(5):420-32. doi: 10.1111/j.1600-0609.2009.01315.x. Epub 2009 Jul 6.

PMID:
19594616

Supplemental Content

Support Center